Market Challenges to MNCH Medicines

R4D presented on a project they have developed that focuses on co-creating a list of context-specific, prioritized solutions to address market challenges that limit access to MNCH medicines at the global level and in each of the five geographies of focus – Ethiopia, Tanzania, Uganda, Kenya, and Kano state, Nigeria. The project’s aim is to enable decision-makers to make well-informed strategic decisions regarding how best to catalytically implement changes to improve access for life-saving MNCH medicines.